Skip to main content

Client News

Abivax publishes a prospectus in the context of its capital increase

23rd February 2023

iOmx Therapeutics appoints Dr. Christine Rothe as new Chief Development Officer

23rd February 2023

Abivax announces successful oversubscribed EUR 130M cross-over financing at market price with top-tier US and European Biotech investors

22nd February 2023

Esperas Pharma, Inc. announces investment from TVM Life Science Innovation I and the Fonds de solidarité FTQ

21st February 2023

Mainz Biomed acquires entire intellectual property portfolio for its colorectal cancer diagnostic test program

21st February 2023

Leading fashion company joins fiber-to-fiber consortium founded by Carbios, On, Patagonia, PUMA and Salomon

18th February 2023

Abivax appoints Dr. Sheldon Sloan, M.D., as Chief Medical Officer

17th February 2023

Ahead of its business plan, Andera Partners approaches 4 billion euros in assets under management and announces a new 2028 target of 6 to 8 billion euros

16th February 2023

Newron reports striking one-year interim efficacy results from its Phase II clinical trial evaluating evenamide as add-on therapy for patients with treatment-resistant schizophrenia

16th February 2023

Mainz Biomed expands european commercial footprint and enters markets in Spain and UK

15th February 2023